These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 23149085)

  • 1. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
    J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
    Sang CN; Sathyanarayana R; Sweeney M;
    Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
    Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF
    Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia.
    Jensen MP; Hsu PH; Vanhove GF
    Pain Med; 2012 Aug; 13(8):1059-66. PubMed ID: 22757655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
    Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
    Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.
    Gupta A; Li S
    Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin.
    Freeman R; Wallace MS; Sweeney M; Backonja MM
    Pain Med; 2015 Oct; 16(10):2000-11. PubMed ID: 26115203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
    Parsons B; Tive L; Huang S
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
    Wallace MS; Irving G; Cowles VE
    Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials.
    Wang J; Zhu Y
    J Dermatolog Treat; 2017 Feb; 28(1):65-77. PubMed ID: 27798973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
    Backonja MM; Canafax DM; Cundy KC
    Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia.
    Chen C; Han CH; Sweeney M; Cowles VE
    J Pharm Sci; 2013 Apr; 102(4):1155-64. PubMed ID: 23381946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.
    Sandercock D; Cramer M; Biton V; Cowles VE
    Diabetes Res Clin Pract; 2012 Sep; 97(3):438-45. PubMed ID: 22497967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin for chronic neuropathic pain in adults.
    Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin: Interaction of Patient Demographics, Disease Characteristics, and Efficacy Outcomes.
    Kantor D; Panchal S; Patel V; Bucior I; Rauck R
    J Pain; 2015 Dec; 16(12):1300-1311. PubMed ID: 26409117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
    Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E
    Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).
    Zhang L; Rainka M; Freeman R; Harden RN; Bell CF; Chen C; Graff O; Harding K; Hunter S; Kavanagh S; Laurijssens B; Schwartzbach C; Warren S; McClung C
    J Pain; 2013 Jun; 14(6):590-603. PubMed ID: 23602345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.